NeoCardial Technologies

NeoCardial is focused on developing an innovative extra-ventricular assist device (eVAD) aimed at treating heart failure without the need for heart incisions or blood contact. The company is comprised of a skilled team of medical, scientific, engineering, and entrepreneurial professionals dedicated to improving cardiac treatment and prolonging the... lives of patients with advanced heart failure. Their eVAD enhances the heart's pumping efficacy through mild direct compression, allowing for a minimally invasive approach that avoids the complications associated with traditional ventricular assist devices. NeoCardial is currently refining their technology and preparing for regulatory approvals to conduct clinical trials on humans.Read More